Meditation Program for Cancer Patients and Caregivers
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how two supportive care programs might enhance the mental health and quality of life for cancer patients and their family caregivers. Participants will either join a meditation program (known as Mindfulness Meditation or Meditation Therapy) or engage in discussion sessions with a counselor. This trial targets individuals diagnosed with stage IV cancer (advanced cancer that has spread to other parts of the body) who haven't experienced worsening symptoms in the past three months. A family caregiver willing to participate must also be involved. Either the patient or caregiver should currently experience significant distress, as measured by a common distress screening tool. As an unphased trial, this study offers a unique opportunity to contribute to understanding supportive care's impact on mental health and quality of life.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on supportive care programs, so it's unlikely that medication changes are required, but you should confirm with the trial coordinators.
What prior data suggests that this meditation program is safe for cancer patients and caregivers?
Research has shown that mindfulness meditation can safely and effectively support cancer patients and their caregivers. In one study, 89 cancer patients who participated in a mindfulness meditation program experienced significant reductions in mood issues and stress, indicating that the program is generally well-received and carries minimal risk. Another study found that meditation can improve the overall quality of life for cancer patients, with benefits lasting for months. Additionally, just one meditation class provided symptom relief for both patients and caregivers. These studies highlight the safety and potential benefits of meditation for improving well-being without serious side effects.12345
Why are researchers excited about this trial?
Researchers are excited about this meditation program for cancer patients and caregivers because it offers a holistic approach that complements traditional medical treatments like chemotherapy and radiation. Unlike standard care, which primarily focuses on the physical aspects of cancer, this program emphasizes mental and emotional well-being by incorporating family discussions and meditation sessions. The unique feature of this program is its family-centric approach, where participants engage in online sessions together, fostering a supportive environment that can enhance coping mechanisms and potentially improve overall quality of life.
What evidence suggests that this meditation program is effective for cancer patients and caregivers?
Research has shown that meditation can greatly benefit cancer patients. In one study, a 7-week mindfulness meditation program significantly reduced mood problems and stress for 89 cancer patients receiving outpatient care. Another study found that meditation improved mindfulness, social support, well-being, and spirituality among cancer patients. A review of several studies also demonstrated that online mindfulness programs reduced psychological issues like depression in cancer survivors. In this trial, participants in the Attention Control arm will join a meditation program, which might enhance the mental health and quality of life for cancer patients and their families.23678
Who Is on the Research Team?
Kathrin Milbury, MD,PHD
Principal Investigator
MD Anderson
Are You a Good Fit for This Trial?
This trial is for adults with stage IV breast, thoracic, gastrointestinal, gynecological, or genitourinary cancer who've had no disease progression for at least 3 months. They must have a caregiver willing to join the study and both should be able to understand English or Spanish. Participants need an ECOG performance status of ≤2 and a distress score ≥4.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Behavioral Intervention
Participants will take part in a discussion program with 4 sessions over 4 weeks
Attention Control
Participants will take part in a meditation program with up to 4 sessions
Follow-up
Participants are monitored for psychological wellbeing and quality of life
What Are the Treatments Tested in This Trial?
Interventions
- Meditation Program
Meditation Program is already approved in United States, European Union, Canada for the following indications:
- Anxiety
- Depression
- Stress Management
- Pain Management
- Quality of Life Improvement
- Anxiety Disorders
- Depressive Disorders
- Chronic Pain Management
- Stress Reduction
- Mental Health Support
- Palliative Care
- Symptom Management
- Well-being Enhancement
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor